Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tim Lyles
AddedMar 31, 2024
UpdatedMay 31, 2026
Tim Lyles

Tim Lyles

Board Member, Seno Medical Instruments

Crunchbase

Tim Lyles's Career

Seno Medical Instruments
Seno Medical Instruments

San Antonio, TX, US

Board Member· Board
CeloNova Biosciences
CeloNova Biosciences

San Antonio, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tim Lyles's Career

Seno Medical Instruments
Seno Medical Instruments
Series C$60.7M752019San Antonio, TX, US
Board Member· Board

Leadership at Seno Medical Instruments

Tom UmbelTom UmbelCEO
Harry R. JacobsonHarry R. JacobsonBoard Member
Gregory OberholtzerGregory OberholtzerBoard Member
Janet CampbellJanet CampbellFounder

Similar to Seno Medical Instruments

TomoWave LaboratoriesTomoWave LaboratoriesHouston, TX, USMedical Imagingest. 2010TomoWave LaboratoriesHouston, TX, US · est. 2010

TomoWave Laboratories: Pioneering optoacoustic tomography and laser ultrasound systems for advanced cancer detection.

Angel · $71.4k30
POC Medical SystemsPOC Medical SystemsLivermore, CA, USMedical Equipmentest. 2013POC Medical SystemsLivermore, CA, US · est. 2013

POC Medical Systems: A California-based provider of innovative breast cancer screening equipment.

Series A · $22.1M11
Delphinus Medical TechnologiesDelphinus Medical TechnologiesPlymouth, MI, USMedical Devicesest. 2010Delphinus Medical TechnologiesPlymouth, MI, US · est. 2010

US-based Delphinus Medical Technologies designs and provides 3D full-breast ultrasound imaging devices.

Series A · $109.1M75
C4 ImagingC4 ImagingBellaire, TX, USMedical Devicesest. 2009C4 ImagingBellaire, TX, US · est. 2009

C4 Imaging: Personalizing patient care with precise image-guided medical devices.

Pre-Seed · $7.2M8
CeloNova Biosciences
CeloNova Biosciences
Acquired$20.8M02000San Antonio, TX, US
Board Member· Board

Leadership at CeloNova Biosciences

Goetz RichterGoetz RichterFounder
Denny WareDenny WareBoard Member
Marty LandonMarty LandonBoard Member

Tim Lyles's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Tim Lyles

Huan LeHuan LeCEO · MedCare PartnersDavid HovdaDavid HovdaBoard Member · Pro-DexDon ByrneDon ByrneBoard Member · ChartSpan Medical TechnologiesJack TawilJack TawilBoard Member · MedpodJeff McLarenJeff McLarenBoard Member · HealthStreamDavid AuerbachDavid AuerbachBoard Member · Alan AI